ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631477 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631477; 2) Community: the network communities that were significantly associated with the response to NSC 631477; 3) Molecule: the relationships between components within communities and NSC 631477; 4) MDR: the compounds that were significantly associated with the NSC 631477.

NSC Compound Enrichment Correlation
NSC 732954 Null 0.0385613993886001 0.15156355
NSC 736163 pyrazoline derivative 0.0385613993886001 0.20789456
NSC 746930 Null 0.0385613993886001 0.40614198
NSC 747459 Null 0.0385613993886001 0.24741551
NSC 750040 Null 0.0385613993886001 0.33727155
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0385613993886001 0.16355887
NSC 752503 2,7-Bis-[2-(3,4,5-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone dipara-toluensulfonate dihydrate salt 0.0385613993886001 0.25567244
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0385613993886001 0.37530276
NSC 756188 GSK718429A 0.0385613993886001 0.29968285
NSC 759878 Irinotecan hydrochloride (USAN) 0.0385613993886001 0.078854625
Total:162  Current:129    [First] [Prev] [Next] [Last]